By-health Co., Ltd. (300146.SZ)
Guangzhou, CN
By-health Co., Ltd. operates internationally as a producer and vendor of a diverse range of dietary supplements. Its comprehensive portfolio encompasses essential nutrients like proteins, vitamins, and minerals, in addition to specialized solutions addressing numerous health needs. These include offerings for supporting bone and joint integrity, promoting cardiovascular and brain health, enhancing beauty, boosting immunity, assisting with weight control, improving vigor, nourishing eyes, aiding sleep, managing blood sugar, optimizing memory, and supporting reproductive wellness. The company also provides tailored nutrition for children, expectant mothers, and the well-being of the liver, digestive tract, and stomach. Sold under the "By-health" and "GymMax" labels, these products are designed for all age groups—children, adult men and women, and seniors—and are distributed globally through a multi-channel approach involving wholesale partners, retail stores, and online platforms. Established in 1995, By-health Co., Ltd. is based in Guangzhou, China. The firm was previously known as Guangdong By-Health Biotechnology Co., Ltd. until its rebranding in April 2012.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.09% | -1.11% | -6.95% | -18.99% | -19.85% | -18.65% | -16.35% | -57.94% | -73.19% | -27.14% | +59.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%-9.1% Q1'26: +4.3% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+23.7% ★ Q1'26: -11.1% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+15.9% Q1'26: +3.3% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+14.3% ★ Q1'26: +23.7% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+12.1% ★ Q1'26: +21.9% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%-2.5% ★ Q1'26: -0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.88× ★ Q1'26: 0.56× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.27B
est: 2.27B (+0.0%)
|
2.31B
est: 2.31B (+0.0%)
|
3.11B
est: 3.11B (0.0%)
|
4.35B
est: 4.35B (0.0%)
|
5.26B
est: 5.37B (-2.1%)
|
6.09B
est: 6.20B (-1.8%)
|
7.43B
est: 7.44B (-0.1%)
|
7.86B
est: 7.75B (+1.5%)
|
9.41B
est: 8.42B (+11.7%)
|
6.84B
est: 7.17B (-4.7%)
|
6.22B
est: 6.31B (-1.4%)
|
6.99B
6.91B – 7.09B
+10.8% YoY
|
7.77B
7.27B – 8.28B
+11.2% YoY
|
8.65B
8.61B – 8.69B
+11.3% YoY
|
| EBITDA |
698.78M
est: 505.10M (+38.3%)
|
638.04M
est: 514.71M (+24.0%)
|
857.77M
est: 693.45M (+23.7%)
|
1.22B
est: 970.00M (+26.2%)
|
1.43B
est: 1.20B (+19.1%)
|
1.57B
est: 1.38B (+13.3%)
|
2.01B
est: 1.66B (+21.3%)
|
1.77B
est: 1.73B (+2.7%)
|
2.07B
est: 1.76B (+17.4%)
|
964.15M
est: 1.50B (-35.8%)
|
1.18B
est: 1.32B (-10.8%)
|
1.46B
1.45B – 1.49B
+10.8% YoY
|
1.63B
1.52B – 1.73B
+11.2% YoY
|
1.81B
1.80B – 1.82B
+11.3% YoY
|
| EBIT |
638.76M
est: 439.05M (+45.5%)
|
557.51M
est: 447.40M (+24.6%)
|
759.34M
est: 602.77M (+26.0%)
|
1.08B
est: 843.16M (+27.7%)
|
1.18B
est: 1.04B (+13.0%)
|
1.36B
est: 1.20B (+13.2%)
|
1.80B
est: 1.44B (+24.6%)
|
1.56B
est: 1.50B (+4.0%)
|
1.85B
est: 1.50B (+23.4%)
|
744.04M
est: 1.27B (-41.6%)
|
888.49M
est: 1.12B (-20.7%)
|
1.24B
1.23B – 1.26B
+10.8% YoY
|
1.38B
1.29B – 1.47B
+11.2% YoY
|
1.54B
1.53B – 1.54B
+11.3% YoY
|
| Net Income |
635.50M
est: 761.58M (-16.6%)
|
535.21M
est: 618.47M (-13.5%)
|
766.26M
est: 833.22M (-8.0%)
|
1.00B
est: 1.19B (-15.6%)
|
-355.89M
est: -384.83M (+7.5%)
|
1.52B
est: 1.56B (-2.1%)
|
1.75B
est: 1.72B (+1.7%)
|
1.39B
est: 1.50B (-7.4%)
|
1.75B
est: 1.09B (+59.9%)
|
652.83M
est: 795.40M (-17.9%)
|
782.15M
est: 729.32M (+7.2%)
|
824.69M
648.69M – 895.81M
+13.1% YoY
|
961.87M
682.33M – 1.05B
+16.6% YoY
|
1.13B
715.48M – 1.18B
+17.2% YoY
|
| SGA |
823.72M
est: 994.77M (-17.2%)
|
881.13M
est: 1.01B (-13.1%)
|
1.20B
est: 1.37B (-12.0%)
|
1.68B
est: 1.91B (-12.0%)
|
2.08B
est: 2.36B (-11.9%)
|
2.25B
est: 2.72B (-17.3%)
|
2.86B
est: 3.27B (-12.4%)
|
3.56B
est: 3.40B (+4.7%)
|
4.35B
est: 3.89B (+11.8%)
|
3.59B
est: 3.32B (+8.2%)
|
3.02B
est: 2.92B (+3.5%)
|
3.23B
3.19B – 3.28B
+10.8% YoY
|
3.59B
3.36B – 3.82B
+11.2% YoY
|
4.00B
3.98B – 4.02B
+11.3% YoY
|
| EPS |
0.44
est: 0.44 (-0.7%)
|
0.37
est: 0.36 (+2.8%)
|
0.52
est: 0.49 (+7.2%)
|
0.69
est: 0.69 (-0.2%)
|
-0.24
est: -0.22 (-7.1%)
|
0.96
est: 0.91 (+5.9%)
|
1.06
est: 1.00 (+5.6%)
|
0.82
est: 0.87 (-5.8%)
|
1.03
est: 0.64 (+60.6%)
|
0.39
est: 0.47 (-17.8%)
|
0.47
est: 0.45 (+3.9%)
|
0.46
0.39 – 0.53
+1.9% YoY
|
0.52
0.41 – 0.63
+12.4% YoY
|
0.58
0.43 – 0.71
+12.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.08% | 29.0K | 0.65% |
| 2 | Goldman Sachs MarketBeta Total International Equity ETF GXUS | 0.01% | 84.1K | 0.18% |
| 3 | State Street SPDR S&P China ETF GXC | 0.01% | 52.5K | 0.59% |
| 4 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 116.4K | 0.19% |
| 5 | Franklin FTSE China ETF FLCH | 0.01% | 18.1K | 0.19% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 115.5K | 0.46% |
| 7 | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF EMCR | 0.00% | 2.0K | 0.15% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 18.3K | 0.44% |
| 9 | Vanguard International High Dividend Yield ETF VYMI | 0.00% | 452.2K | 0.07% |
| 10 | Franklin FTSE Asia ex Japan ETF FLAX | 0.00% | 961.62 | 0.19% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bailin He | Chief Financial Officer | — | male |
| Hong Chen | Deputy General Manager | — | male |
| Jinyin Tang | Secretary to the Board of Directors | — | female |
| Zhicheng Lin | Chief Executive Officer & Non-Independent Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300146.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
